News + Filings Holdings
|
|
Atlas Venture Life Science Advisors, LLC
|
|
Changes: All | New | Increased | Decreased | Sold Out |
Portfolio as of: |
| Name | Ticker | Class | Shares | Change | Value | Change | % Port | % OS | Hist | Date |
|
Spero Therapeutics, Inc.
| SPRO | Common | 1,013,438 | -17,722 | 1,469,485,000 | 1,467,423,000 | 0.18 | 1.93 |
Hist
| 06/30/2023 |
|
Akero Therapeutics, Inc.
| AKRO | Common | 594,251 | -400,000 | 27,745,579,000 | 27,711,725,000 | 3.45 | 1.19 |
Hist
| 06/30/2023 |
|
Aerovate Therapeutics, Inc.
| AVTE | Common | 2,039,249 | -288,660 | 34,973,120,000 | 34,934,523,000 | 4.35 | |
Hist
| 06/30/2023 |
|
Replimune Group, Inc.
| REPL | Common | 2,098,300 | -1,010,000 | 48,722,526,000 | 48,668,846,000 | 6.06 | 3.63 |
Hist
| 06/30/2023 |
|
Day One Biopharmaceuticals, Inc.
| DAWN | Common | 7,608,394 | -560,777 | 90,844,224,000 | 90,680,596,000 | 11.31 | 10.34 |
Hist
| 06/30/2023 |
|
Kymera Therapeutics, Inc.
| KYMR | Common | 5,858,262 | -1,017,436 | 134,681,443,000 | 134,531,759,000 | 16.76 | 10.62 |
Hist
| 06/30/2023 |
|
|
|
|